
As the U.S. IPO market opens back up, here’s how biotech CEO Marc de Garidel says business leaders can capitalize. But how does a company actually go public—and what does a CEO need to do to ada...
As the U.S. IPO market opens back up, here’s how biotech CEO Marc de Garidel says business leaders can capitalize. But how does a company actually go public—and what does a CEO need to do to ada...